PYC 1.04% 9.7¢ pyc therapeutics limited

Ann: AGM Company Presentation, page-34

  1. 5,342 Posts.
    lightbulb Created with Sketch. 688
    I didnt realise it was stated quite so clearly in the chairmans update that we are certainly no longer interested in the type of "relatively small" collaborations we signed previously.

    The fact we have changed to current targets coupled with Hottods post stating company said
    "Phylogica has a near-term opportunity to improve the commercial attractiveness of our platform by showing that we can deliver a cargo class of interest into a target cell of interest more efficiently than the relevant competitive technology."
    Would certainly indicate PYC are hoping for a significant deal well in excess of previous up fronts?

    From Ceo update
    "And to use Phylogica’s human capital to the best effect, it was
    decided to direct resources to the pursuit of those strategic objectives in preference
    to negotiating relatively small co-development deals. For while these offered the
    prospect of near-term cash funding, usually they did not offer development of the
    company’s science in the key areas of focus. At this stage the priority for the team is
    the development of our science."

    "We are not interested in small deals", yet "we have a near term opportunity to improve the commercial attractiveness of our platform" certainly sounds like we are not just hoping, we do have genuine interest.
 
watchlist Created with Sketch. Add PYC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.